These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29938784)

  • 1. Brain derived neurotropic factor single nucleotide polymorphism Val66Met and serum protein levels are associated with development of vincristine-induced peripheral neuropathy in patients with lymphoma.
    Azoulay D; Nasser R; Sharon R; Simanovich L; Akria L; Shaoul E; Horowitz NA
    Br J Haematol; 2019 Apr; 185(1):175-177. PubMed ID: 29938784
    [No Abstract]   [Full Text] [Related]  

  • 2. Low brain-derived neurotrophic factor protein levels and single-nucleotide polymorphism Val66Met are associated with peripheral neuropathy in type II diabetic patients.
    Azoulay D; Abed S; Sfadi A; Sheleg O; Shaoul E; Shehadeh M; Kaykov E; Nodelman M; Bashkin A
    Acta Diabetol; 2020 Jul; 57(7):891-898. PubMed ID: 32124075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Plasma Pro-Brain-Derived Neurotrophic Factor (proBDNF)/Mature Brain-Derived Neurotrophic Factor (mBDNF) Levels with BDNF Gene Val66Met Polymorphism in Alcohol Dependence.
    Mo M; Fu XY; Zhang XL; Zhang SC; Zhang HQ; Wu L; Li JL; Zhou L
    Med Sci Monit; 2021 Aug; 27():e930421. PubMed ID: 34415897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BDNF Val66Met is Associated with Pre-existing but not with Paclitaxel-induced Peripheral Neuropathy in an Israeli Cohort of Breast Cancer Patients.
    Leibovici A; Sharon R; Azoulay D
    Isr Med Assoc J; 2018 Dec; 20(12):746-748. PubMed ID: 30550003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Chemotherapy-Induced Peripheral Neuropathy in Patients with Lymphoma and Myeloma: the Roles of Brain-Derived Neurotropic Factor Protein Levels and A Gene Polymorphism.
    Azoulay D; Giryes S; Nasser R; Sharon R; Horowitz NA
    J Clin Neurol; 2019 Oct; 15(4):511-516. PubMed ID: 31591840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF Val66Met genetic variation and its plasma level in patients with morbid obesity: A case-control study.
    Zamani M; Hosseini SV; Behrouj H; Erfani M; Dastghaib S; Ahmadi M; Shamsdin SA; Mokarram P
    Gene; 2019 Jul; 705():51-54. PubMed ID: 31004714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression.
    Skibinska M; Groszewska A; Kapelski P; Rajewska-Rager A; Pawlak J; Dmitrzak-Weglarz M; Szczepankiewicz A; Twarowska-Hauser J
    Pharmacol Rep; 2018 Feb; 70(1):55-59. PubMed ID: 29331787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between dietary quality, serum brain-derived neurotrophic factor (BDNF) level, and the Val66met polymorphism in predicting depression.
    Froud A; Murphy J; Cribb L; Ng CH; Sarris J
    Nutr Neurosci; 2019 Jul; 22(7):513-521. PubMed ID: 29280414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients.
    Kang SG; Choi JE; An H; Lim SW; Lee HJ; Han C; Kim YK; Kim SH; Cho SN; Lee MS; Joe SH; Jung IK; Kim L
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1545-8. PubMed ID: 18602732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF Val66Met polymorphism and serum concentrations of BDNF with smoking in Thai males.
    Suriyaprom K; Tungtrongchitr R; Thawnashom K; Pimainog Y
    Genet Mol Res; 2013 Oct; 12(4):4925-33. PubMed ID: 24301752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patients.
    Ikenouchi-Sugita A; Yoshimura R; Kishi T; Umene-Nakano W; Hori H; Katsuki A; Saito K; Iwata N; Tanaka Y; Nakamura J
    Hum Psychopharmacol; 2011; 26(4-5):348-51. PubMed ID: 21678493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations.
    Lang UE; Hellweg R; Sander T; Gallinat J
    Mol Psychiatry; 2009 Feb; 14(2):120-2. PubMed ID: 19156154
    [No Abstract]   [Full Text] [Related]  

  • 14. An Inherited Genetic Variant in CEP72 Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia.
    Stock W; Diouf B; Crews KR; Pei D; Cheng C; Laumann K; Mandrekar SJ; Luger S; Advani A; Stone RM; Larson RA; Evans WE
    Clin Pharmacol Ther; 2017 Mar; 101(3):391-395. PubMed ID: 27618250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum BDNF levels and the BDNF Val66Met polymorphism with the sleep pattern in healthy young adults.
    Saitoh K; Furihata R; Kaneko Y; Suzuki M; Takahashi S; Uchiyama M
    PLoS One; 2018; 13(6):e0199765. PubMed ID: 29944703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in serum brain-derived neurotrophic factor in met allele carriers of the BDNF Val66Met polymorphism is specific to males.
    Bus BA; Arias-Vasquez A; Franke B; Prickaerts J; de Graaf J; Voshaar RC
    Neuropsychobiology; 2012 Jun; 65(4):183-7. PubMed ID: 22538247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
    Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
    JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Risk-Taking Behaviour and Brain-Derived Neurotrophic Factor Val66Met Polymorphism Correlates to Decreased Serum Brain-Derived Neurotrophic Factor Level in Heroin Users.
    Roviš D; Černelič Bizjak M; Vasiljev Marchesi V; Petelin A; Jenuš T; Vidic S; Drevenšek G; Jenko Pražnikar Z
    Eur Addict Res; 2018; 24(4):189-200. PubMed ID: 30134233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism affects sympathetic tone in a gender-specific way.
    Chang CC; Chang HA; Chen TY; Fang WH; Huang SY
    Psychoneuroendocrinology; 2014 Sep; 47():17-25. PubMed ID: 25001952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Val66Met polymorphism and serum brain-derived neurotrophic factor in bipolar disorder: an open-label trial.
    Grande I; Magalhães PV; Chendo I; Stertz L; Fries GR; Cereser KM; Cunha ÂB; Gói P; Kunz M; Udina M; Martín-Santos R; Frey BN; Vieta E; Kapczinski F
    Acta Psychiatr Scand; 2014 May; 129(5):393-400. PubMed ID: 23957567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.